91ɫƵ

header-logo
Research Group Lab Hall

Therapeutic Accelerator Program (TAP) at the 91ɫƵ

The Therapeutic Accelerator Program (TAP) in the Department of Pharmacology & Toxicology serves 91ɫƵ and Clinical & Translational Science Institute of Southeast Wisconsin partner institutions. The process of translating research ideas into technologies that improve human health is many steps and requires the assistance of different teams with diverse expertise. TAP catalyzes the bench to beside journey, bridging the gap between basic research and the development process. TAP provides advising, project-based funding opportunities, and connections to our network of resources to de-risk and advance technologies along the path to commercialization.

mcw-taps-program-logo

Services

  • Project-based funding opportunities for therapeutic development (Drugs, devices, diagnostics, platform technologies, HealthTech)
  • Expert advising
  • Therapeutic product development and entrepreneurship education

Therapeutic Accelerator Program (TAP) Pillars of Support

Teaching & Education

  • Modern Drug Discovery & Development course
  • Professional development course for trainees
  • Formal entrepreneurship and therapeutic product development education for faculty and trainees developing new technologies
  • Translational Workforce Development

Advising

  • Help investigators start the product development process and identify next critical steps
  • Facilitate internal and external collaborations
  • Concept validation and independent scientific review by panels of experts
  • Guide the scientific milestones of the development process and connect investigators to the business, legal, regulatory, and capital resources

Project Funding

  • Competitive project-based funding
  • $1.4M in funding support awarded by TAP
  • $8M awarded to projects by external sources
  • Executed 25 funded projects
  • 112 funding proposals received

Therapeutic Accelerator Program (TAP) Impact

  • 1 marketed product
  • 2 licensed technologies
  • 2 additional technologies in talks for licensing
  • 5 startup companies incorporated
  • 7 additional startup companies assisted
  • 9 patents awarded
  • 10 additional patents filed/pending
  • 4 new intellectual property disclosures
  • 2 clinical trials
  • Over 200 consultations

Contact Us

General inquiries and advising

Kristin Ciezki, PhD

Director, Therapeutic Accelerator Program

kciezki@mcw.edu | (414) 955-4605

 

Do you have an idea that you think might be patentable? Please reach out to 91ɫƵ's Office of Technology Development at inventions@mcw.edu.